DIGENE CORP. v. Ventana Medical Systems, Inc.

511 F. Supp. 2d 407, 2007 U.S. Dist. LEXIS 42408, 2007 WL 1697027
District Court, D. Delaware·Decided June 12, 2007·No. C.A. 01-752-MPT·Published·Cited by 2 cases

Opinion

MEMORANDUM ORDER

MARY PAT THYNGE, United States Magistrate Judge.

Currently before the court is defendant Beckman Coulter, Inc.’s (“Beckman”) motion to dismiss Digene Corporation’s (“Di-gene”) action against it as res judicata. 1 For the reasons discussed below, Beck-man’s motion is granted.

BACKGROUND 2

On November 19, 2001 Digene filed a complaint against Ventana Medical Systems, Inc. (“Ventana”) for willful infringement of United States Patent Nos. 4,849,-331 (“the '331 patent”) and 4,849,332 (“the '332 patent”) in conjunction with the development, manufacture, marketing, sales, and offers for sale of its INFORM® HPV High Risk Probe and its INFORM® HPV Low Risk Probe Products. 3 Digene further alleged that Ventana willfully induced others to infringe the patents-in-suit. 4 In the initial complaint, Digene sought, among other things, damages for Ventana’s past infringement, enhanced damages, and attorneys’ fees for Ventana’s willful infringement, and an injunction against Ventana’s continued infringement. 5 On February 2, 2002, Ventana answered the complaint, denying infringement and raising several defenses, including the affirmative defense that its allegedly infringing activities are licensed under the '332 patent. 6

*409 On September 23, 2002, Ventana and Beckman executed an Asset Purchase Agreement (the “2002 APA”), which provided that Ventana would purchase Beck-man’s entire right, title and interest in certain assets, including rights under a 1991 SLA between Instituí Pasteur and Beckman. 7 On October 18, 2002, Digene moved for leave to file an Amended Complaint, 8 which the court granted on December 10, 2002. 9 On December 13, 2002, Digene filed its Amended Complaint, adding Beckman as a defendant and additional claims, including civil conspiracy. 10 On December 27, 2002, Beckman filed a motion to compel arbitration, to the stay proceedings, and to dismiss the conspiracy claim in the Amended Complaint. 11

On January 28, 2003, Digene moved for leave to file a Second Amended Complaint (“SAC”). 12 Leave was granted by the court, 13 and the SAC was deemed filed on March 5, 2003. 14 In that complaint, Di-gene accuses Beckman of contributory infringement or inducement of infringement of the '332 patent (Count II), tortious interference with business relations with regard to the '332 patent (Count III) and civil conspiracy for conspiring with Ventana to infringe or induce others to infringe the '332 patent (Count IV). 15

On May 7, 2004, the court ordered Di-gene and Beckman to arbitration and stayed this case pending the outcome of that arbitration. 16 In so ordering arbitration, the court found that the claims, that is, Counts II through IV of the SAC, “arise out of conduct associated with Di-gene’s rights under the '332 patent ... and the factual underpinnings ... necessarily implicate the CLA and its arbitration provisions____” 17 As a result, the court concluded that

Beckman may arbitrate Digene’s claims against it that implicate Beckman’s rights under the CLA; that is, Beck-man’s rights to receive a sublicense from IP to develop, make and have made, use, sell, market and otherwise commercially exploit products and services pertaining to HPV types 31, 35, 43 and 56.... 18

Arbitration took place during March 2006 and the arbitration panel issued its award on July 27, 2006. 19 The court lifted the stay of these proceedings on August 15, 2006 20 and on August 29, 2006, Beck-man filed the present motion under consideration. 21

DISCUSSION

Motion to Dismiss

In reviewing a motion to dismiss under Federal Rule of Civil Procedure 12(b)(6), *410 the court must assume the truth of all well pleaded factual allegations set forth in the complaint, and must construe them in the light most favorable to the non-moving party. 22 “While a court will accept well-plead allegations as true for the purposes of the motion, it will not accept unsupported conclusions, unwarranted inferences, or sweeping legal conclusions cast in the form of factual allegation.” 23 Although under a Rule 12(b) review, the focus is on the pleadings, “matters of public record, orders, exhibits attached to the complaint and items appearing in the record of the case” may also be part of the court’s consideration. 24 Despite the literal language of Rule 12(b), conversion 25 is not automatically required when a court considers documents and other materials outside the pleadings. 26 As a result, this court may reference orders and other items of record in the present case, including its decision on arbitration, motions filed by the parties and the arbitration award, which is incorporated in the stipulation and order to confirm that award and enter judgment thereon, under a motion to dismiss.

Summary Judgment 27

A grant of summary judgment pursuant to Fed.R.Civ.P. 56(c) is appropriate “if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.” 28 A Rule 56(c) movant bears the burden of establishing the lack of a genuinely disputed material fact by demonstrating “that there is an absence of evidence to support the nonmoving party’s case.” 29 “Where the *411

Free access — add to your briefcase to read the full text and ask questions with AI

DIGENE CORP. v. Ventana Medical Systems, Inc., 511 F. Supp. 2d 407, 2007 U.S. Dist. LEXIS 42408, 2007 WL 1697027 (D. Del. 2007).

511 F. Supp. 2d 407 (DIGENE CORP. v. Ventana Medical Systems, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related